Taiwan · Delayed Price · Currency is TWD Sinew Pharma Statistics
Total Valuation
Sinew Pharma has a market cap or net worth of TWD 3.69 billion. The enterprise value is 2.53 billion.
| Market Cap | 3.69B |
| Enterprise Value | 2.53B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sinew Pharma has 71.31 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 71.29M |
| Shares Outstanding | 71.31M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +100.18% |
| Owned by Insiders (%) | 17.67% |
| Owned by Institutions (%) | 3.23% |
| Float | 42.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 78,446.38 |
| PB Ratio | 3.55 |
| P/TBV Ratio | 3.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 46.43, with a Debt / Equity ratio of 0.01.
| Current Ratio | 46.43 |
| Quick Ratio | 46.35 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | -119.03 |
Financial Efficiency
Return on equity (ROE) is -10.85% and return on invested capital (ROIC) is -7.52%.
| Return on Equity (ROE) | -10.85% |
| Return on Assets (ROA) | -7.40% |
| Return on Invested Capital (ROIC) | -7.52% |
| Return on Capital Employed (ROCE) | -12.73% |
| Weighted Average Cost of Capital (WACC) | 7.49% |
| Revenue Per Employee | 904 |
| Profits Per Employee | -2.28M |
| Employee Count | 52 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.65% in the last 52 weeks. The beta is 0.59, so Sinew Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +9.65% |
| 50-Day Moving Average | 61.17 |
| 200-Day Moving Average | 48.07 |
| Relative Strength Index (RSI) | 33.76 |
| Average Volume (20 Days) | 76,534 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sinew Pharma had revenue of TWD 47,000 and -118.43 million in losses. Loss per share was -1.66.
| Revenue | 47,000 |
| Gross Profit | 37,000 |
| Operating Income | -133.08M |
| Pretax Income | -118.43M |
| Net Income | -118.43M |
| EBITDA | -127.75M |
| EBIT | -133.08M |
| Loss Per Share | -1.66 |
Balance Sheet
The company has 995.27 million in cash and 12.27 million in debt, with a net cash position of 983.00 million or 13.78 per share.
| Cash & Cash Equivalents | 995.27M |
| Total Debt | 12.27M |
| Net Cash | 983.00M |
| Net Cash Per Share | 13.78 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 14.55 |
| Working Capital | 999.98M |
Cash Flow
In the last 12 months, operating cash flow was -97.67 million and capital expenditures -658,000, giving a free cash flow of -98.33 million.
| Operating Cash Flow | -97.67M |
| Capital Expenditures | -658,000 |
| Depreciation & Amortization | 5.33M |
| Net Borrowing | -5.76M |
| Free Cash Flow | -98.33M |
| FCF Per Share | -1.38 |
Margins
| Gross Margin | 78.72% |
| Operating Margin | -283,142.55% |
| Pretax Margin | -251,980.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sinew Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
| Earnings Yield | -3.21% |
| FCF Yield | -2.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sinew Pharma has an Altman Z-Score of 65.37 and a Piotroski F-Score of 1.
| Altman Z-Score | 65.37 |
| Piotroski F-Score | 1 |